Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Journal of Chemotherapy (Florence, Italy)|February 26, 2013
Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokineticsBrian T Tsuji, Yoriko Harigaya, Alan J Lesse, et al.
The Annals of Pharmacotherapy|March 20, 2008
Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infectionPamela A Moise, Rochelle S Castro, Caroline Sul, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 18, 2008
Oral administration of fomepizole produces similar blood levels as identical intravenous doseJeanna Marraffa, Alan Forrest, William Grant, et al.
International Journal of Antimicrobial Agents|May 21, 2013
Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureusRachel L Soon, Stuart J Turner, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variablesJeffrey P Hammel, Sujata M Bhavnani, Ronald N Jones, et al.
Plos One|August 20, 2011
Multiple nuclear gene phylogenetic analysis of the evolution of dioecy and sex chromosomes in the genus SileneGabriel A B Marais, Alan Forrest, Esther Kamau, et al.
Toxicology Letters|February 16, 2006
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whitesVanessa Gonzalez Covarrubias, Sukhwinder S Lakhman, Alan Forrest, et al.
Annals of Plastic Surgery|April 16, 2004
Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitisKevin W Broder, Pamela A Moise, Raymond O Schultz, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotypeBrian T Tsuji, Christof von Eiff, Pamela A Kelchlin, et al.
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Journal of Chemotherapy (Florence, Italy)|February 26, 2013
Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokineticsBrian T Tsuji, Yoriko Harigaya, Alan J Lesse, et al.
The Annals of Pharmacotherapy|March 20, 2008
Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infectionPamela A Moise, Rochelle S Castro, Caroline Sul, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 18, 2008
Oral administration of fomepizole produces similar blood levels as identical intravenous doseJeanna Marraffa, Alan Forrest, William Grant, et al.
International Journal of Antimicrobial Agents|May 21, 2013
Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureusRachel L Soon, Stuart J Turner, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variablesJeffrey P Hammel, Sujata M Bhavnani, Ronald N Jones, et al.
Plos One|August 20, 2011
Multiple nuclear gene phylogenetic analysis of the evolution of dioecy and sex chromosomes in the genus SileneGabriel A B Marais, Alan Forrest, Esther Kamau, et al.
Toxicology Letters|February 16, 2006
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whitesVanessa Gonzalez Covarrubias, Sukhwinder S Lakhman, Alan Forrest, et al.
Annals of Plastic Surgery|April 16, 2004
Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitisKevin W Broder, Pamela A Moise, Raymond O Schultz, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotypeBrian T Tsuji, Christof von Eiff, Pamela A Kelchlin, et al.
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.
Pageof 18